---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-125696"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:21:27.858703+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer Healthcare amends ABL facility: $41.5M commitment increase, maturity extended to 2028

## Summary
- Revolving credit commitments increased by $41.5M (exhibit shows $41.5M, not $25M cited in filing summary).
- Maturity extended to five years from Dec 8, 2023 (Dec 8, 2028), subject to springing maturity.
- Deutsche Bank NY Branch exited as lender; a new lender joined with assignments and reallocations.
- Amendment provides increased flexibility on restricted payments, debt incurrence, and borrowing base.
- Borrower paid amendment fees: 0.10% of outstanding commitments plus 0.15% of new money commitments.

## SEC filing metadata
- accession: 0001104659-23-125696
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/tm2332799d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-125696
- JSON: https://secwatch.observer/filing/0001104659-23-125696.json
- Plain text: https://secwatch.observer/filing/0001104659-23-125696.txt

## Key facts
- Debt Financings
  Prestige Consumer Healthcare Inc. amended revolving credit of $25 million increase in the aggregate revolving commitments with Citibank, N.A., as administrative agent, L/C issuer and swing line lender maturing five years from the effective date of the Amendment.
  - Instrument: revolving credit
  - Principal: $25 million increase in the aggregate revolving commitments
  - Counterparty: Citibank, N.A., as administrative agent, L/C issuer and swing line lender
  - Maturity: five years from the effective date of the Amendment
  - Event: amendment
  source text: The Amendment provides for (i) a $25 million increase in the aggregate revolving commitments of all lenders under the Credit Agreement, (ii) an extension of the maturity date of the Credit Agreement to the date that is five years from the effective date of the Amendment
  evidence_url: https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm
- Material Agreements
  Prestige Consumer Healthcare Inc. amended Amendment No. 9 with Citibank, N.A., as administrative agent, L/C issuer and swing line lender (effective 2023-12-08).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Citibank, N.A., as administrative agent, L/C issuer and swing line lender
  - Effective: 2023-12-08
  source text: On December 8, 2023, Prestige Consumer Healthcare Inc. (the “ Company ”) and its wholly owned subsidiary, Prestige Brands, Inc. (the “ Borrower ”) entered into Amendment No. 9 (the “ Amendment ”) to the ABL Credit Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.